Free Trial

Pyxis Oncology (PYXS) Insider Trading & Ownership

Pyxis Oncology logo
$1.69 +0.15 (+9.74%)
(As of 12/20/2024 05:40 PM ET)

Pyxis Oncology (NASDAQ:PYXS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.80%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$174,146.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get PYXS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PYXS Insider Buying and Selling by Quarter

Pyxis Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/26/2024Pamela Ann ConnealyCFOBuy88,850$1.96$174,146.00  
(Data available from 1/1/2013 forward)

PYXS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Pyxis Oncology includes Jitendra Wadhane, Lara Sullivan, Mark Chin, Pamela Ann Connealy, and Pfizer Inc. Learn more on insiders at PYXS.

9.80% of Pyxis Oncology stock is owned by insiders. Learn more on PYXS's insider holdings.

The following insiders have purchased PYXS shares in the last 24 months: Jitendra Wadhane ($17,875.00), Pamela Ann Connealy ($214,774.10), and Pfizer Inc ($4,999,999.44).

Insiders have purchased a total of 1,933,870 PYXS shares in the last 24 months for a total of $5,232,648.54 bought.

The following insider sold PYXS shares in the last 24 months: Lara Sullivan ($70,146.10).

Insiders have sold a total of 31,541 Pyxis Oncology shares in the last 24 months for a total of $70,146.10 sold.

Pyxis Oncology Key Executives

  • Dr. Lara S. Sullivan M.D.
    MBA, CEO, President & Director
  • Ms. Pamela Yanchik Connealy M.B.A. (Age 62)
    CFO & COO
    Compensation: $709.7k
  • Dr. Ken Kobayashi FACP (Age 63)
    M.D., Chief Medical Officer
    Compensation: $314.08k
  • Mr. Jitendra Wadhane (Age 43)
    Chief Accounting Officer, Senior VP of Finance & Corporate Controller
  • Dr. Balu N. Balasubramanian Ph.D.
    Interim Chief Technology Officer
  • Dr. Jan Pinkas Ph.D.
    Chief Scientific Officer
  • Dr. Charles T. Gombar Ph.D.
    Senior Vice President of Portfolio & Program Management


This page (NASDAQ:PYXS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners